CHEBI:50427 - platelet aggregation inhibitor

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name platelet aggregation inhibitor
ChEBI ID CHEBI:50427
Definition A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Stars This entity has been manually annotated by the ChEBI Team.
ChEBI Ontology
Outgoing platelet aggregation inhibitor (CHEBI:50427) is a hematologic agent (CHEBI:50248)
Incoming β-benzoyloxypaeoniflorin (CHEBI:132791) has role platelet aggregation inhibitor (CHEBI:50427)
δ-guaiene (CHEBI:63447) has role platelet aggregation inhibitor (CHEBI:50427)
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (CHEBI:140850) has role platelet aggregation inhibitor (CHEBI:50427)
(E)-3-tosylacrylonitrile (CHEBI:85928) has role platelet aggregation inhibitor (CHEBI:50427)
(S)-glaucine (CHEBI:5373) has role platelet aggregation inhibitor (CHEBI:50427)
12-HPEPE (CHEBI:78909) has role platelet aggregation inhibitor (CHEBI:50427)
12-HPEPE(1−) (CHEBI:78078) has role platelet aggregation inhibitor (CHEBI:50427)
4,4'-dihydroxybenzyl sulfone (CHEBI:65786) has role platelet aggregation inhibitor (CHEBI:50427)
6-oxoprostaglandin E1 (CHEBI:28269) has role platelet aggregation inhibitor (CHEBI:50427)
cis-ferulic acid (CHEBI:76117) has role platelet aggregation inhibitor (CHEBI:50427)
N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide (CHEBI:133247) has role platelet aggregation inhibitor (CHEBI:50427)
S-nitroso-L-cysteine (CHEBI:138935) has role platelet aggregation inhibitor (CHEBI:50427)
acadesine (CHEBI:28498) has role platelet aggregation inhibitor (CHEBI:50427)
acetylsalicylic acid (CHEBI:15365) has role platelet aggregation inhibitor (CHEBI:50427)
ACT-333679 (CHEBI:90848) has role platelet aggregation inhibitor (CHEBI:50427)
actinodaphnine (CHEBI:2444) has role platelet aggregation inhibitor (CHEBI:50427)
aglafolin (CHEBI:65374) has role platelet aggregation inhibitor (CHEBI:50427)
anagrelide (CHEBI:142290) has role platelet aggregation inhibitor (CHEBI:50427)
anagrelide hydrochloride (CHEBI:55345) has role platelet aggregation inhibitor (CHEBI:50427)
angelitriol (CHEBI:132402) has role platelet aggregation inhibitor (CHEBI:50427)
angelol-J (CHEBI:132768) has role platelet aggregation inhibitor (CHEBI:50427)
asperenone (CHEBI:133813) has role platelet aggregation inhibitor (CHEBI:50427)
azelastine (CHEBI:2950) has role platelet aggregation inhibitor (CHEBI:50427)
azelastine hydrochloride (CHEBI:2951) has role platelet aggregation inhibitor (CHEBI:50427)
bassiatin (CHEBI:65465) has role platelet aggregation inhibitor (CHEBI:50427)
BAY 41-2272 (CHEBI:142435) has role platelet aggregation inhibitor (CHEBI:50427)
benzo[d]isothiazol-3-one (CHEBI:167099) has role platelet aggregation inhibitor (CHEBI:50427)
bianfugenine (CHEBI:132719) has role platelet aggregation inhibitor (CHEBI:50427)
bis-(4-hydroxybenzyl)ether (CHEBI:65501) has role platelet aggregation inhibitor (CHEBI:50427)
cangrelor (CHEBI:90841) has role platelet aggregation inhibitor (CHEBI:50427)
cangrelor tetrasodium (CHEBI:90836) has role platelet aggregation inhibitor (CHEBI:50427)
carmoxirole (CHEBI:64200) has role platelet aggregation inhibitor (CHEBI:50427)
carmoxirole hydrochloride (CHEBI:64199) has role platelet aggregation inhibitor (CHEBI:50427)
cilostazol (CHEBI:31401) has role platelet aggregation inhibitor (CHEBI:50427)
clonixin (CHEBI:76200) has role platelet aggregation inhibitor (CHEBI:50427)
clonixin lysine salt (CHEBI:76201) has role platelet aggregation inhibitor (CHEBI:50427)
clopidogrel (CHEBI:37941) has role platelet aggregation inhibitor (CHEBI:50427)
clopidogrel sulfate (CHEBI:3759) has role platelet aggregation inhibitor (CHEBI:50427)
cyclomorusin A (CHEBI:132868) has role platelet aggregation inhibitor (CHEBI:50427)
cytochalasin B (CHEBI:23527) has role platelet aggregation inhibitor (CHEBI:50427)
diallyl trisulfide (CHEBI:78492) has role platelet aggregation inhibitor (CHEBI:50427)
dipyridamole (CHEBI:4653) has role platelet aggregation inhibitor (CHEBI:50427)
droxicam (CHEBI:76133) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban (CHEBI:85973) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban tosylate (CHEBI:85975) has role platelet aggregation inhibitor (CHEBI:50427)
edoxaban tosylate hydrate (CHEBI:85974) has role platelet aggregation inhibitor (CHEBI:50427)
EET (CHEBI:64007) has role platelet aggregation inhibitor (CHEBI:50427)
eptifibatide (CHEBI:291902) has role platelet aggregation inhibitor (CHEBI:50427)
forskolin (CHEBI:42471) has role platelet aggregation inhibitor (CHEBI:50427)
galgravin (CHEBI:132648) has role platelet aggregation inhibitor (CHEBI:50427)
herquline B (CHEBI:66012) has role platelet aggregation inhibitor (CHEBI:50427)
hydroxysafflor yellow A (CHEBI:139030) has role platelet aggregation inhibitor (CHEBI:50427)
iloprost (CHEBI:63916) has role platelet aggregation inhibitor (CHEBI:50427)
isobavachalcone (CHEBI:28106) has role platelet aggregation inhibitor (CHEBI:50427)
isotanshinone IIB (CHEBI:66098) has role platelet aggregation inhibitor (CHEBI:50427)
lificiguat (CHEBI:142430) has role platelet aggregation inhibitor (CHEBI:50427)
methyl brevifolincarboxylate (CHEBI:66711) has role platelet aggregation inhibitor (CHEBI:50427)
milrinone (CHEBI:50693) has role platelet aggregation inhibitor (CHEBI:50427)
miroprofen (CHEBI:76249) has role platelet aggregation inhibitor (CHEBI:50427)
neobavaisoflavone (CHEBI:66614) has role platelet aggregation inhibitor (CHEBI:50427)
nisoldipine (CHEBI:7577) has role platelet aggregation inhibitor (CHEBI:50427)
oleoyl danshenxinkun A (CHEBI:66819) has role platelet aggregation inhibitor (CHEBI:50427)
oleoyl neocryptotanshinone (CHEBI:66820) has role platelet aggregation inhibitor (CHEBI:50427)
procainamide (CHEBI:8428) has role platelet aggregation inhibitor (CHEBI:50427)
prostaglandin E1 (CHEBI:15544) has role platelet aggregation inhibitor (CHEBI:50427)
sapinmusaponin Q (CHEBI:66169) has role platelet aggregation inhibitor (CHEBI:50427)
sapinmusaponin R (CHEBI:66170) has role platelet aggregation inhibitor (CHEBI:50427)
sciadopitysin (CHEBI:9050) has role platelet aggregation inhibitor (CHEBI:50427)
selexipag (CHEBI:90844) has role platelet aggregation inhibitor (CHEBI:50427)
sevoflurane (CHEBI:9130) has role platelet aggregation inhibitor (CHEBI:50427)
sophoraflavanone B (CHEBI:50207) has role platelet aggregation inhibitor (CHEBI:50427)
splitomicin (CHEBI:75272) has role platelet aggregation inhibitor (CHEBI:50427)
surfactin (CHEBI:29681) has role platelet aggregation inhibitor (CHEBI:50427)
surfactin C (CHEBI:71978) has role platelet aggregation inhibitor (CHEBI:50427)
syringetin (CHEBI:18215) has role platelet aggregation inhibitor (CHEBI:50427)
tetramethylpyrazine (CHEBI:133246) has role platelet aggregation inhibitor (CHEBI:50427)
ticagrelor (CHEBI:68558) has role platelet aggregation inhibitor (CHEBI:50427)
ticlopidine (CHEBI:9588) has role platelet aggregation inhibitor (CHEBI:50427)
treprostinil (CHEBI:50861) has role platelet aggregation inhibitor (CHEBI:50427)
troglitazone (CHEBI:9753) has role platelet aggregation inhibitor (CHEBI:50427)
vitexin (CHEBI:16954) has role platelet aggregation inhibitor (CHEBI:50427)
vorapaxar (CHEBI:82702) has role platelet aggregation inhibitor (CHEBI:50427)
vorapaxar sulfate (CHEBI:83314) has role platelet aggregation inhibitor (CHEBI:50427)
yinyanghuo A (CHEBI:66492) has role platelet aggregation inhibitor (CHEBI:50427)
yinyanghuo B (CHEBI:66493) has role platelet aggregation inhibitor (CHEBI:50427)
partial prostacyclin agonist (CHEBI:51577) is a platelet aggregation inhibitor (CHEBI:50427)
platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433) is a platelet aggregation inhibitor (CHEBI:50427)
Synonym Source
platelet aggregation inhibitors ChEBI
Last Modified
25 October 2018